Latest News about NVS
Recent news which mentions NVS
Why Novartis, BioVie, Esperion And VBI Are Moving Today
January 15, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 15, 2021
January 15, 2021
From Benzinga
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
January 14, 2021
From Motley Fool
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
These Were the 5 Best Diagnostics Stocks of 2020
January 09, 2021
From Motley Fool
European stocks and U.S. equity futures trade higher as investors welcome U.S. stimulus package and Brexit deal
December 28, 2020
From MarketWatch
From Benzinga
2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started
December 23, 2020
From Motley Fool
Should Investors Consider This Biotech Takeover Target?
December 21, 2020
From Motley Fool
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
December 18, 2020
From Motley Fool
Why Mesoblast Stock Plummeted on Friday
December 18, 2020
From Motley Fool
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
December 18, 2020
From Benzinga
As bitcoin busts out new records, these market watchers see $250,000 and even $400,000 on the horizon
December 17, 2020
From MarketWatch
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
December 16, 2020
From Benzinga
From Benzinga
The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics
December 13, 2020
From Benzinga
Why Is Everyone Talking About Gamida Cell Stock?
December 10, 2020
From Motley Fool
3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
From Benzinga
Novartis Kicks Off $2.5B Share Buyback Program On Strong Pipeline Growth
November 24, 2020
Tickers
NVS
From Benzinga
3 Healthcare IPOs to Watch This Month
November 21, 2020
From Motley Fool
Why Mesoblast Stock Is Blasting Off Today
November 20, 2020
From Motley Fool
European stocks up for third straight day as investors cling to COVID-19 vaccine hopes
November 11, 2020
From MarketWatch
Everything you need to know about BioNTech and the married couple behind the COVID-19 vaccine at the front of a global race
November 10, 2020
From MarketWatch
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
From Benzinga
AstraZeneca Misses Q3 Earnings Consensus, Expects Covid-19 Vaccine Trial Results This Year
November 05, 2020
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.